Healthcare Private Equity Transactions under Scrutiny: Midyear Review

At the end of last year, Holland & Knight predicted that “the current enforcement environment will continue into 2024 and will focus heavily on the healthcare industry, along with private equity transactions or ‘roll-ups.’ Companies in those industries should expect heightened scrutiny leading to more antitrust investigations and litigation.” As the summer draws to a close, the speed of proposed legislation at the state level, as well as the states taking first-mover positions, have been a surprise.

Read the full article: Healthcare Private Equity Transactions under Scrutiny: Midyear Review //

Source: https://www.healthcarebusinesstoday.com/healthcare-private-equity-transactions-under-scrutiny-midyear-review/

Scroll to Top